Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Intra-Cellular's Lumateperone Brings Mixed Results In Bipolar Depression

Jul 08 2019

• By Joseph Haas

Bipolar disorder psychological state diagnosis concept, flat vector illustration, expressive happiness and depression, unstable patient mood, contrasting feelings with cheerful and frustrated person - Vector — Bipolar disorder is characterized by episodes of mania and depression

Related Content

Keeping Track: FDA Clears Motegrity And Second Herceptin Biosimilar, But Rebuffs SpecGx's Oxycodone

Dec 17 2018

Keeping Track: FDA Approves First Generic Advair, But Alkermes And Sunovion Land CRLs

Feb 02 2019

Surprise Failure for Intra-Cellular Therapies’ Schizophrenia Drug Sends Shares Tumbling

Sep 29 2016

Allergan Confident Data Support Bipolar Depression Addition To Vraylar's Label

Apr 05 2018

Related Companies

Intra-Cellular Therapies, Inc.

AstraZeneca PLC

Allergan plc

Alkermes plc

Additional Topics

Clinical Trials Drug Approval Standards Research & Development Business Strategies Neurology BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window